Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications: A Prespecified Secondary Analysis of a Randomized Clinical Trial

Référence de l’article : Peterson GG, Pu J, Magid DJ, et al. Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications: A Prespecified Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. Published online June 02, 2021. doi:10.1001/jamacardio.2021.1565 Lecture proposée par : JP Fauvel The Million Hearts® Cardiovascular Disease Risk Reduction est une étude…

Final Report of a Trial of Intensive versus Standard Blood-Pressure Control

Référence de l’article : SPRINT Research Group, Lewis CE, et al. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2021 May 20;384(20):1921-1930. doi: 10.1056/NEJMoa1901281. PMID: 34010531. Lecture proposée par : JP Fauvel Voici les résultats finaux de SPRINT qui a randomisé 9361 hypertendus présentant un risque accru de maladie CV (sans diabète ni…

Adrenocorticotropic Hormone-Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies

Référence de l’article : Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A. Adrenocorticotropic Hormone-Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies. Hypertension. 2021 May 17:HYPERTENSIONAHA12117248. doi: 10.1161/HYPERTENSIONAHA.121.17248. Epub ahead of print. PMID: 33993726. Lecture proposée par : L Amar Le cathétérisme des…

Association between antihypertensive treatment and adverse events: systematic review and meta-analysis

Référence de l’article : Albasri A, Hattle M, Koshiaris C, Dunnigan A, Paxton B, Fox S E et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis BMJ 2021; 372 :n189 doi:10.1136/bmj.n189 Lecture proposée par : JP Fauvel Une méta-analyse portant sur les effets secondaires des traitements anti-hypertenseurs a été publiée dans le BMJ. Le critère…

Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients

Référence de l’article : Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, Penso L, Herlemont P, Sbidian E, Weill A, Dray-Spira R, Zureik M. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients. Hypertension. 2021 Mar 3;77(3):833-842. doi: 10.1161/HYPERTENSIONAHA.120.16314. Epub 2021 Jan 11. PMID: 33423528. Lecture proposée par : JP…